The relationship between Vitamins B12, B9, and D and polycystic ovarian syndrome
A review article
Keywords:
homocysteine, Polycystic Ovarian Syndrome, Vitamin B12, Vitamin B9, Vitamin DAbstract
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age, with a constellation of symptoms including hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology. Approximately 8–13% of women worldwide are diagnosed with PCOS. PCOS affects women of reproductive age, regardless of their ethnic background, although signs and symptoms may vary by ethnicity. Symptoms include obesity, hirsutism, acne, amenorrhea, infertility, and occasionally menorrhagia. It is particularly important to consider the presence of clinical and biochemical signs of hyperandrogenism in female patients. According to previous studies, vitamin deficiencies may play a role in the pathophysiology of PCOS, leading to insulin resistance, inflammation, dyslipidemia, and obesity, all of which are associated with the syndrome. The aim of the study: A review of the effect of some vitamins on polycystic ovary syndrome.
Downloads
References
Al-Daghri, N. M., Al-Attas, O. S., Alkharfy, K. M., Khan, N., Mohammed, A. K., Vinodson, B., ... & Alokail, M. S. (2014). Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency. Gene, 542(2), 129-133. https://doi.org/10.1016/j.gene.2014.03.044
Alvarez, J. A., & Ashraf, A. (2010). Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. International journal of endocrinology, 2010(1), 351385.
Asanidze, E., Kristesashvili, J., & Andguladze, S. (2019). Correlation Between Levels Of Homocysteine, Anti-Müllerian Hormone and Insulin Resistance in PCOS Patients with Recurrent Miscarriage. Georgian Medical News, (290), 25-29.
Bhushan, R., & Sinha, P. (2022). Correlation of serum homocysteine levels and hyperinsulinaemia with body mass index in polycystic ovarian syndrome. Journal of human reproductive sciences, 15(1), 34-41.
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016). The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction, 31(12), 2841-2855.
Choudhary, A., Jain, S., & Chaudhari, P. (2017). Prevalence and symptomatology of polycystic ovarian syndrome in Indian women: is there a rising incidence. Int J Reprod Contracept Obstet Gynecol, 6(11), 4971-5.
Cowan, S., Lim, S., Alycia, C., Pirotta, S., Thomson, R., Gibson-Helm, M., ... & Moran, L. (2023). Lifestyle management in polycystic ovary syndrome–beyond diet and physical activity. BMC endocrine disorders, 23(1), 14.
De Groot, P. C., Dekkers, O. M., Romijn, J. A., Dieben, S. W., & Helmerhorst, F. M. (2011). PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human reproduction update, 17(4), 495-500.
Deswal, R., Narwal, V., Dang, A., & Pundir, C. S. (2020). The prevalence of polycystic ovary syndrome: a brief systematic review. Journal of human reproductive sciences, 13(4), 261-271.
Di Simone, N., Riccardi, P., Maggiano, N., Piacentani, A., D'Asta, M., Capelli, A., & Caruso, A. (2004). Effect of folic acid on homocysteine-induced trophoblast apoptosis. Molecular human reproduction, 10(9), 665-669.
Engevik, M. A., Morra, C. N., Röth, D., Engevik, K., Spinler, J. K., Devaraj, S., ... & Versalovic, J. (2019). Microbial metabolic capacity for intestinal folate production and modulation of host folate receptors. Frontiers in microbiology, 10, 2305.
Eskandari, Z., Sadrkhanlou, R. A., Nejati, V., & Tizro, G. (2016). PCOS women show significantly higher homocysteine level, independent to glucose and E2 level. International journal of reproductive biomedicine, 14(8), 495.
Ganie, M. A., Marwaha, R. K., Aggarwal, R., & Singh, S. (2010). High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: a case–control study. European journal of endocrinology, 162(6), 1117-1122.
Garg, G., Kachhawa, G., Ramot, R., Khadgawat, R., Tandon, N., Sreenivas, V., ... & Gupta, N. (2015). Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study. Endocrine connections, 4(2), 108-116.
Goyette, P., Pai, A., Milos, R., Frosst, P., Tran, P., Chen, Z., ... & Rozen, R. (1998). Gene structure of human and mouse methylenetetrahydrofolate reductase (MTHFR). Mammalian Genome, 9, 652-656.
Günalan, E., Yaba, A., & Yılmaz, B. (2018). The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review. Journal of the Turkish German Gynecological Association, 19(4), 220.
Hager, M., Nouri, K., Imhof, M., Egarter, C., & Ott, J. (2019). The impact of a standardized micronutrient supplementation on PCOS-typical parameters: a randomized controlled trial. Archives of Gynecology and Obstetrics, 300, 455-460.
Hanna, M., Jaqua, E., Nguyen, V., & Clay, J. B. (2022). Vitamins: functions and uses in medicine. Perm. J, 26(2), 89-97.
Irani, M., & Merhi, Z. (2014). Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review. Fertility and sterility, 102(2), 460-468. https://doi.org/10.1016/j.fertnstert.2014.04.046
Iyer, S. S., & Cheng, G. (2012). Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Critical Reviews™ in Immunology, 32(1).
Jakubowski, H., & Głowacki, R. (2011). Chemical biology of homocysteine thiolactone and related metabolites. Advances in clinical chemistry, 55, 81-103.
Joshi, B., Mukherjee, S., Patil, A., Purandare, A., Chauhan, S., & Vaidya, R. (2014). A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian journal of endocrinology and metabolism, 18(3), 317-324.
Kaya, C., Cengiz, S. D., & Satıroğlu, H. (2009). Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS. Reproductive biomedicine online, 19(5), 721-726. https://doi.org/10.1016/j.rbmo.2009.06.005
Kilicdag, E. B., Bagis, T., Tarim, E., Aslan, E., Erkanli, S., Simsek, E., ... & Kuscu, E. (2005). Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Human Reproduction, 20(6), 1521-1528.
Krul-Poel, Y. H. M., Snackey, C., Louwers, Y., Lips, P. T. A. M., Lambalk, C. B., Laven, J. S. E., & Simsek, S. (2013). The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. European journal of endocrinology, 169(6), 853-865.
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 98(12), 4565-4592.
Liew, S. C., & Gupta, E. D. (2015). Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. European journal of medical genetics, 58(1), 1-10. https://doi.org/10.1016/j.ejmg.2014.10.004
Lyon, P., Strippoli, V., Fang, B., & Cimmino, L. (2020). B vitamins and one-carbon metabolism: implications in human health and disease. Nutrients, 12(9), 2867.
McCarty MF 2000 Increased homocysteine associated with smoking, chronic inflammation, and ageing may reflect acute phase induction of pyridoxal phosphatase activity. Medical Hypotheses 55, 289–293.
McCarty, M. F. (2000). High-dose pyridoxine as an ‘anti-stress’ strategy. Medical Hypotheses, 54(5), 803-807. https://doi.org/10.1054/mehy.1999.0955
Meng, Y., Chen, X., Peng, Z., Liu, X., Sun, Y., & Dai, S. (2016). Association between high serum homocysteine levels and biochemical characteristics in women with polycystic ovarian syndrome: a systematic review and meta-analysis. PLoS One, 11(6), e0157389.
Moini, A., Shirzad, N., Ahmadzadeh, M., Hosseini, R., Hosseini, L., & Sadatmahalleh, S. J. (2015). Comparison of 25-hydroxyvitamin D and calcium levels between polycystic ovarian syndrome and normal women. International Journal of Fertility & Sterility, 9(1), 1.
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010). Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human reproduction update, 16(4), 347-363.
Murphy, M. E., & Westmark, C. J. (2020). Folic acid fortification and neural tube defect risk: analysis of the food fortification initiative dataset. Nutrients, 12(1), 247.
Nafiye, Y., Sevtap, K., Muammer, D., Emre, O., Senol, K., & Leyla, M. (2010). The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome. Fertility and sterility, 93(6), 1864-1869. https://doi.org/10.1016/j.fertnstert.2008.12.024
Nelen, W. L., Bulten, J., Steegers, E. A., Blom, H. J., Hanselaar, A. G., & Eskes, T. K. (2000). Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Human Reproduction, 15(4), 954-960.
Qi, X., Zhang, B., Zhao, Y., Li, R., Chang, H. M., Pang, Y., & Qiao, J. (2017). Hyperhomocysteinemia promotes insulin resistance and adipose tissue inflammation in PCOS mice through modulating M2 macrophage polarization via estrogen suppression. Endocrinology, 158(5), 1181-1193.
Rasha A.H. Alathary, Rusul A. Abass, Seenaa Taqi Mansour Al muhtaser, Ali A. Al-fahham. (2025). Biochemistry, Pathophysiology and Clinical Importance of IL-4: A Review Article. International Journal of Health & Medical Research, 44-47.
Rashidi, B., Haghollahi, F., Shariat, M., & Zayerii, F. (2009). The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwanese Journal of Obstetrics and Gynecology, 48(2), 142-147.
Rasquin, L.I., Anastasopoulou, C., & Mayrin, J.V. (2024). Polycystic Ovarian Disease. In Stat Pearls; Stat Pearls Publishing: Treasure Island FL, USA.
Rawat, A. (2020). Polycystic ovarian syndrome: role of nutrition, vitamins, and minerals—myoinositol and vitamin D3. Journal of South Asian Federation of Obstetrics and Gynaecology, 12(2), 63-64.
Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A. M., ... & Meczekalski, B. (2021). Chronic low grade inflammation in pathogenesis of PCOS. International journal of molecular sciences, 22(7), 3789.
Saadeh, N., Alfaqih, M. A., Mansour, H., Khader, Y. S., Saadeh, R., Al-Dwairi, A., & Nusier, M. (2018). Serum homocysteine is associated with polycystic ovarian syndrome in Jordan. Biomedical Reports, 9(5), 439-445.
Shen, J. Y., Xu, L., Ding, Y., & Wu, X. Y. (2023). Effect of vitamin supplementation on polycystic ovary syndrome and key pathways implicated in its development: A Mendelian randomization study. World Journal of Clinical Cases, 11(23), 5468.
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023). Polycystic ovary syndrome: etiology, current management, and future therapeutics. Journal of clinical medicine, 12(4), 1454.
Thomson, R. L., Spedding, S., & Buckley, J. D. (2012). Vitamin D in the aetiology and management of polycystic ovary syndrome. Clinical endocrinology, 77(3), 343-350.
Thornburgh, S., & Gaskins, A. J. (2022). B vitamins, polycystic ovary syndrome, and fertility. Current Opinion in Endocrinology, Diabetes and Obesity, 29(6), 554-559.
Xiong, Y., Bian, C., Lin, X., Wang, X., Xu, K., & Zhao, X. (2020). Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer. Bioscience Reports, 40(7), BSR20200995.
Zeng, Y., Li, F. F., Yuan, S. Q., Tang, H. K., Zhou, J. H., He, Q. Y., ... & Yang, Y. D. (2021). Prevalence of hyperhomocysteinemia in China: an updated meta-analysis. Biology, 10(10), 959.
Published
How to Cite
Issue
Section
Copyright (c) 2025 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
